CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY

Scope & Guideline

Shaping the Future of Pharmacological Discoveries

Introduction

Delve into the academic richness of CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageMulti-Language
ISSN0008-4212
PublisherCANADIAN SCIENCE PUBLISHING
Support Open AccessNo
CountryCanada
TypeJournal
Convergefrom 1964 to 2024
AbbreviationCAN J PHYSIOL PHARM / Can. J. Physiol. Pharmacol.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA

Aims and Scopes

The Canadian Journal of Physiology and Pharmacology focuses on the intersection of physiology and pharmacology, addressing various aspects of human health and disease through experimental and clinical research. Its scope encompasses a broad range of topics, particularly those related to cardiovascular health, pharmacotherapy, and the physiological impacts of various substances and interventions.
  1. Cardiovascular Physiology and Pharmacology:
    The journal emphasizes research on cardiovascular health, exploring mechanisms of disease, treatment strategies, and physiological responses, particularly in women and vulnerable populations.
  2. Sex Differences in Health and Disease:
    A consistent focus on gender-specific differences in disease presentation, treatment responses, and outcomes, particularly in cardiovascular diseases, reflects the journal's commitment to understanding health disparities.
  3. Pharmacological Interventions and Drug Development:
    Research related to the pharmacological effects of various compounds, including traditional drugs and novel therapeutic agents, is a core area, with studies investigating mechanisms of action, efficacy, and safety.
  4. Molecular and Cellular Mechanisms:
    The journal publishes research that elucidates the molecular pathways involved in health and disease, including studies on cellular signaling, gene expression, and the impact of various compounds on these processes.
  5. Translational Research and Clinical Applications:
    There is a strong emphasis on bridging the gap between laboratory findings and clinical applications, with studies aimed at improving therapeutic strategies and patient care.
The Canadian Journal of Physiology and Pharmacology is evolving with emerging themes that reflect current scientific trends and societal health challenges. Recent publications indicate a shift towards more specialized and relevant topics that address contemporary issues in physiology and pharmacology.
  1. Impact of Lifestyle and Dietary Interventions:
    There is a growing emphasis on how dietary components and lifestyle changes affect health, particularly concerning cardiovascular health and metabolic diseases, which reflects a broader interest in preventive medicine.
  2. Mental Health and Cardiovascular Interactions:
    Research exploring the intersection of mental health and cardiovascular disease is gaining attention, highlighting the importance of psychosocial factors in physical health outcomes.
  3. Regenerative Medicine and Stem Cell Research:
    Emerging studies on stem cell therapies and regenerative approaches for cardiac repair and other conditions indicate a trend towards innovative treatment strategies that harness the body's healing capabilities.
  4. Pharmacogenomics and Personalized Medicine:
    The integration of pharmacogenomic data to tailor drug therapies to individual patients is increasingly featured, reflecting a shift towards personalized approaches in pharmacotherapy.
  5. Gender-Specific Pharmacology and Therapeutics:
    An increasing focus on how gender affects drug metabolism, efficacy, and safety is evident, emphasizing the need for sex-specific research in pharmacological studies.

Declining or Waning

While the journal has a robust focus on cardiovascular health and pharmacology, certain themes appear to be declining in prominence based on recent publications. This may indicate a shift in research priorities or emerging interests within the field.
  1. Basic Science Research with Limited Clinical Relevance:
    There is a noticeable reduction in papers solely focused on basic physiological mechanisms without clear clinical implications, as the journal increasingly prioritizes translational research.
  2. Animal Models in Isolation:
    Research focusing exclusively on animal models without direct relevance to human physiology or clinical outcomes appears to be less frequent, reflecting a trend towards studies that connect animal findings to human health.
  3. Traditional Pharmacological Approaches:
    As new therapeutic modalities and personalized medicine approaches gain traction, traditional pharmacological studies that do not incorporate modern techniques or insights into individual variability are becoming less common.

Similar Journals

Comprehensive Physiology

Bridging Theory and Practice in Physiology
Publisher: WILEYISSN: 2040-4603Frequency: 4 issues/year

Comprehensive Physiology is a premier journal published by WILEY, dedicated to the profound exploration of physiological science. With an impact factor that underscores its significance within the field, this journal serves as a pivotal resource for researchers, professionals, and students alike, ensuring access to cutting-edge studies and reviews that span various domains of physiology. It stands proudly in the Q1 category across multiple subfields including Medicine (miscellaneous), Physiology, and Medical Physiology, reflecting its outstanding position within the scientific community. Evaluated within prestigious bibliometric ranks, it boasts an impressive Scopus ranking, placing it in the 12th percentile for medical physiology and 23rd percentile in biochemical, genetic, and molecular physiology. As it converges from 2011 to 2024, Comprehensive Physiology continues to foster a platform for innovative discoveries and collaborative exchanges, thereby contributing significantly to the advancement of medical knowledge and understanding of physiological processes.

CHINESE JOURNAL OF PHYSIOLOGY

Elevating the discourse in medical physiology.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0304-4920Frequency: 6 issues/year

CHINESE JOURNAL OF PHYSIOLOGY, published by WOLTERS KLUWER MEDKNOW PUBLICATIONS, has been a vital resource since its inception in 1971, catering to the expansive field of physiology. Operating out of Taiwan, this journal addresses critical research in both general and medical physiology, providing a platform for innovative studies that contribute significantly to the understanding of biological processes. With an emphasis on disseminating high-quality, peer-reviewed articles, it holds a Q4 ranking in Physiology and a Q3 ranking in Medical Physiology as of 2023, reflecting its commitment to advancing physiological science. The ISSN for this journal is 0304-4920 and the E-ISSN is 2666-0059. While access options are not available as open access, researchers and professionals can still benefit from its valuable insights. Notably, it ranks #78/113 in Medicine - Physiology and #159/193 in Biochemistry, Genetics, and Molecular Biology - Physiology on Scopus, indicating its growing influence in the scientific community. We invite researchers, professionals, and students alike to explore the wealth of knowledge featured within the pages of the CHINESE JOURNAL OF PHYSIOLOGY.

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Advancing the Frontiers of Pharmacology and Physiology
Publisher: WILEYISSN: 0305-1870Frequency: 12 issues/year

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, published by WILEY, is a premier journal that serves as a vital resource for researchers, professionals, and students in the fields of pharmacology and physiology. With ISSN 0305-1870 and E-ISSN 1440-1681, this journal has established itself as a significant contributor to scientific dialogue since its inception in 1974. Currently spanning until 2024, it consistently publishes cutting-edge research addressing both experimental and clinical advancements in pharmacology and physiology. Recognized for its quality, it holds a Q2 ranking in the 2023 Pharmacology category and notable Q3 rankings in both Physiology and Medical Physiology. The journal's coverage of topical issues not only ensures a robust platform for innovative findings but also fosters collaborations across disciplines. Although not an Open Access journal, its curated content is invaluable for advancing knowledge, as evidenced by its solid Scopus rankings, which place it within the top percentiles of its field. Engaging with this journal means staying at the forefront of research that shapes clinical practices and experimental methodologies.

Current Opinion in Physiology

Shaping Tomorrow’s Understanding of Physiology
Publisher: ELSEVIERISSN: Frequency: 6 issues/year

Current Opinion in Physiology, published by Elsevier, is a leading journal dedicated to the dynamic field of physiology. With an E-ISSN of 2468-8673, this journal provides a platform for the latest insights and perspectives, reflecting the evolving landscape of physiological research. Operating from the United Kingdom, the journal holds a respectable impact factor and is ranked Q2 in both general physiology and medical physiology categories, highlighting its prominence among the global academic community. With Scopus rankings placing it in the 64th and 60th percentiles within its respective categories, Current Opinion in Physiology serves as an essential resource for researchers, professionals, and students eager to stay informed about innovative theories and emerging trends in physiology. The publication emphasizes high-quality reviews that summarize current knowledge and future directions, ensuring readers gain valuable insights applicable in both clinical and research settings.

PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY

Pioneering Discoveries in European Physiology
Publisher: SPRINGER HEIDELBERGISSN: 0031-6768Frequency: 12 issues/year

Pflügers Archiv - European Journal of Physiology, published by Springer Heidelberg, stands at the forefront of physiological research, showcasing groundbreaking studies since its inception in the 1950s. With a distinguished ISSN of 0031-6768 and an E-ISSN of 1432-2013, this esteemed journal maintains a robust reputation, holding Q1 rankings in Clinical Biochemistry, Physiology, and Medical Physiology as of 2023. Its impressive Scopus rankings place it in the top percentile across various categories, including Biochemistry, Genetics and Molecular Biology and Medicine. Pflügers Archiv serves as a vital platform for researchers, professionals, and students, facilitating the dissemination and discussion of advanced physiological concepts and methodologies. Although it does not currently offer open access, its rigorous peer-review process ensures the highest quality publications that contribute significantly to our understanding of physiological science. Explore the depth of physiological research that shapes our academic landscape today.

FASEB JOURNAL

Exploring Molecular Mechanisms for a Healthier Future
Publisher: WILEYISSN: 0892-6638Frequency: 12 issues/year

FASEB JOURNAL, published by Wiley, stands as a leading interdisciplinary platform in the realm of biological sciences, prominently featured in the United States. With an impressive 2023 impact factor placing it in the Q1 category across various fields including Biochemistry, Biotechnology, Genetics, Molecular Biology, and Medicine (miscellaneous), the journal is recognized for its substantial contribution to advancing knowledge and innovation. It serves as a vital resource for researchers, professionals, and students alike, providing high-quality, peer-reviewed articles that explore the molecular and cellular mechanisms underlying health and disease. The FASEB JOURNAL not only emphasizes accessible scientific communication but also fosters collaboration within these dynamic fields, making it an essential publication for anyone engaged in cutting-edge life sciences research. To explore more about the journal's offerings and access its vast repository of scholarly articles, visit their official page.

Physiological Reports

Fostering Collaboration through High-Impact Research
Publisher: WILEYISSN: 2051-817XFrequency: 24 issues/year

Physiological Reports is a pioneering open-access journal published by WILEY, dedicated to advancing the field of physiology through the dissemination of high-quality research. Since its inception in 2013, this journal has provided a platform for innovative studies in both general physiology and medical physiology, making significant contributions to our understanding of biological processes. With an impact factor that reflects its growing influence—as evidenced by its placement in the Q2 category for physiology and medical physiology in 2023—Physiological Reports is positioned as a vital resource for researchers and practitioners alike. The journal encourages the submission of diverse studies ranging from cellular mechanisms to systemic physiology, presenting a unique opportunity for authors to reach a global audience without access barriers. It has established a reputation for rigorous peer review and timely publication, ensuring that cutting-edge research is readily available to stimulate further inquiry and collaboration in the scientific community.

PROGRESS IN CARDIOVASCULAR DISEASES

Elevating Standards in Cardiovascular Research
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0033-0620Frequency: 6 issues/year

PROGRESS IN CARDIOVASCULAR DISEASES is a leading journal in the field of cardiology and cardiovascular medicine, published by W B SAUNDERS CO-ELSEVIER INC. With an impressive impact factor that places it in the esteemed Q1 quartile of its category, this journal ranks among the top 32 out of 387 journals in its field, positioning itself in the 91st percentile. Since its inception in 1958 and continuing until 2024, it has been a prolific source of cutting-edge research, reviews, and clinical insights that contribute significantly to the understanding and treatment of cardiovascular diseases. Although it does not currently offer open access options, the journal's rigorous peer-review process ensures that all published content meets the highest standards of scientific excellence. As a key resource for researchers, practitioners, and students alike, PROGRESS IN CARDIOVASCULAR DISEASES serves as an indispensable tool for advancing knowledge and practice in cardiovascular health.

Frontiers in Physiology

Unleashing innovative insights for health and disease.
Publisher: FRONTIERS MEDIA SAISSN: Frequency: 1 issue/year

Frontiers in Physiology, published by FRONTIERS MEDIA SA, is a leading open-access journal that has been at the forefront of physiological research since its inception in 2010. As a reputable publication based in Switzerland, it aims to foster the dissemination of groundbreaking findings across various domains of physiology, engaging a global audience of scholars and practitioners. With a commendable Q2 ranking in the fields of both general physiology and medical physiology for 2023, this journal stands out in its field, achieving a significant Scopus rank of #32/113 in medical physiology and #58/193 in biochemistry, genetics, and molecular biology. Frontiers in Physiology not only commits to maintaining high scholarly standards but also ensures that all its articles are freely accessible, thereby promoting collaborative knowledge exchange. With a clear focus on advancing our understanding of physiological processes, the journal plays a crucial role in the development of innovative approaches to health and disease, making it an essential resource for researchers, professionals, and students alike.

CELLULAR SIGNALLING

Elevating Insights into Cellular Communication
Publisher: ELSEVIER SCIENCE INCISSN: 0898-6568Frequency: 12 issues/year

CELLULAR SIGNALLING, published by Elsevier Science Inc, is a premier journal within the realm of Cell Biology, boasting an impressive Q2 category ranking as of 2023. With an ISSN of 0898-6568 and an E-ISSN of 1873-3913, the journal has established itself as a critical platform for advancing the understanding of cellular mechanisms and signal transduction pathways since its inception in 1989. Covering a vast array of topics in Biochemistry, Genetics, and Molecular Biology, it ranks notably at 87 out of 285 in the Scopus list, placing it in the 69th percentile among its peers. The journal serves as an invaluable resource for researchers, professionals, and students seeking high-quality, impactful studies that drive forward the field of cellular biology. While it operates under traditional subscription access, its highlights include rigorous peer-reviewed articles, reviews, and insights that continue to shape current scientific discourse.